These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9350912)

  • 1. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).
    Rawles JM
    J Am Coll Cardiol; 1997 Nov; 30(5):1181-6. PubMed ID: 9350912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT).
    Rawles J
    BMJ; 1996 Jan; 312(7025):212-5. PubMed ID: 8563585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).
    Rawles J
    J Am Coll Cardiol; 1994 Jan; 23(1):1-5. PubMed ID: 8277066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.
    BMJ; 1992 Sep; 305(6853):548-53. PubMed ID: 1393033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial salvage with early anistreplase treatment.
    Rawles JM
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III6-10. PubMed ID: 9422856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of left ventricular function after acute myocardial infarction: efficacy of domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial.
    Rawles JM
    Coron Artery Dis; 1993 Sep; 4(9):801-8. PubMed ID: 8287214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of quality adjusted days as a trial endpoint: effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT).
    Rawles J; Light J
    J Epidemiol Community Health; 1993 Oct; 47(5):377-81. PubMed ID: 8289038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian.
    Rawles J; Sinclair C; Jennings K; Ritchie L; Waugh N
    Heart; 1998 Sep; 80(3):231-4. PubMed ID: 9875080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis.
    Rawles J;
    Heart; 2003 May; 89(5):563-4. PubMed ID: 12695474
    [No Abstract]   [Full Text] [Related]  

  • 11. The magnitude of the benefit from preCCU thrombolysis in acute myocardial infarction: a long term follow up.
    Coccolini S; Berti G; Maresta A
    Int J Cardiol; 1998 May; 65 Suppl 1():S49-56. PubMed ID: 9706827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis.
    Boissel JP
    Int J Cardiol; 1995 Aug; 49 Suppl():S29-37. PubMed ID: 7591314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic model.
    Vale L; Steffens H; Donaldson C
    Pharmacoeconomics; 2004; 22(14):943-54. PubMed ID: 15362930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. AIMS Trial Study Group.
    Lancet; 1990 Feb; 335(8687):427-31. PubMed ID: 1968167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.
    European Myocardial Infarction Project Group
    N Engl J Med; 1993 Aug; 329(6):383-9. PubMed ID: 8326971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic evidence of reperfusion occurring before hospital admission. A Grampian Region Early Anistreplase Trial (GREAT) sub-study.
    Trent R; Adams J; Rawles J
    Eur Heart J; 1994 Jul; 15(7):895-7. PubMed ID: 7925509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prehospital thrombolytic therapy in acute myocardial infarction].
    Carlsson J; Schuster HP; Tebbe U
    Anaesthesist; 1997 Oct; 46(10):829-39. PubMed ID: 9424965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of resuscitation and thrombolysis on mortality rate from acute myocardial infarction.
    Trent R; Adams J; Jennings K; Rawles J
    Int J Cardiol; 1995 Mar; 49(1):33-7. PubMed ID: 7607764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.